nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—PAH—gall bladder—celiac disease	0.225	0.237	CbGeAlD
Droxidopa—ADRB3—connective tissue—celiac disease	0.0959	0.101	CbGeAlD
Droxidopa—PAH—blood—celiac disease	0.0845	0.0889	CbGeAlD
Droxidopa—PAH—liver—celiac disease	0.0661	0.0695	CbGeAlD
Droxidopa—ADRA1D—epithelium—celiac disease	0.0513	0.0539	CbGeAlD
Droxidopa—SLC16A10—epithelium—celiac disease	0.0456	0.048	CbGeAlD
Droxidopa—ADRB1—connective tissue—celiac disease	0.0392	0.0413	CbGeAlD
Droxidopa—DDC—liver—celiac disease	0.0377	0.0396	CbGeAlD
Droxidopa—SLC16A10—lymphoid tissue—celiac disease	0.0351	0.0369	CbGeAlD
Droxidopa—SLC16A10—blood—celiac disease	0.033	0.0348	CbGeAlD
Droxidopa—ADRA1A—epithelium—celiac disease	0.0294	0.031	CbGeAlD
Droxidopa—SLC16A10—liver—celiac disease	0.0258	0.0272	CbGeAlD
Droxidopa—ADRA2C—pancreas—celiac disease	0.025	0.0263	CbGeAlD
Droxidopa—ADRA2A—connective tissue—celiac disease	0.0236	0.0248	CbGeAlD
Droxidopa—ADRA1A—lymphoid tissue—celiac disease	0.0227	0.0239	CbGeAlD
Droxidopa—ADRA1A—blood—celiac disease	0.0213	0.0224	CbGeAlD
Droxidopa—ADRA2C—blood—celiac disease	0.0203	0.0214	CbGeAlD
Droxidopa—ADRA2A—pancreas—celiac disease	0.0199	0.021	CbGeAlD
Droxidopa—ADRA1A—liver—celiac disease	0.0167	0.0176	CbGeAlD
Droxidopa—ADRA2A—blood—celiac disease	0.0162	0.0171	CbGeAlD
Droxidopa—ADRA2C—liver—celiac disease	0.0159	0.0167	CbGeAlD
Droxidopa—SLC16A10—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A4—celiac disease	0.00352	0.0711	CbGpPWpGaD
Droxidopa—PAH—SIDS Susceptibility Pathways—RUNX3—celiac disease	0.00163	0.033	CbGpPWpGaD
Droxidopa—SLC16A10—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.00157	0.0318	CbGpPWpGaD
Droxidopa—ADRB3—Calcium Regulation in the Cardiac Cell—RGS1—celiac disease	0.00108	0.0218	CbGpPWpGaD
Droxidopa—DDC—SIDS Susceptibility Pathways—RUNX3—celiac disease	0.00106	0.0214	CbGpPWpGaD
Droxidopa—SLC6A2—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.000937	0.019	CbGpPWpGaD
Droxidopa—PAH—SIDS Susceptibility Pathways—IL10—celiac disease	0.000807	0.0163	CbGpPWpGaD
Droxidopa—SLC16A10—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.000799	0.0161	CbGpPWpGaD
Droxidopa—PAH—Disease—LCT—celiac disease	0.000743	0.015	CbGpPWpGaD
Droxidopa—ADRA1D—Calcium Regulation in the Cardiac Cell—RGS1—celiac disease	0.000701	0.0142	CbGpPWpGaD
Droxidopa—ADRB1—Calcium Regulation in the Cardiac Cell—RGS1—celiac disease	0.000639	0.0129	CbGpPWpGaD
Droxidopa—ADRB2—Calcium Regulation in the Cardiac Cell—RGS1—celiac disease	0.000625	0.0126	CbGpPWpGaD
Droxidopa—PAH—Metabolism—LCT—celiac disease	0.000622	0.0126	CbGpPWpGaD
Droxidopa—ADRA1B—Calcium Regulation in the Cardiac Cell—RGS1—celiac disease	0.000582	0.0118	CbGpPWpGaD
Droxidopa—ADRB3—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.000536	0.0108	CbGpPWpGaD
Droxidopa—DDC—SIDS Susceptibility Pathways—IL10—celiac disease	0.000522	0.0106	CbGpPWpGaD
Droxidopa—ADRA1A—Calcium Regulation in the Cardiac Cell—RGS1—celiac disease	0.000517	0.0104	CbGpPWpGaD
Droxidopa—SLC6A2—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.000476	0.00963	CbGpPWpGaD
Droxidopa—ADRA2B—Platelet activation, signaling and aggregation—PLEK—celiac disease	0.000471	0.00952	CbGpPWpGaD
Droxidopa—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.000459	0.00928	CbGpPWpGaD
Droxidopa—ADRB3—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.000456	0.00921	CbGpPWpGaD
Droxidopa—ADRA2C—Platelet activation, signaling and aggregation—PLEK—celiac disease	0.00044	0.00889	CbGpPWpGaD
Droxidopa—ADRA2B—G alpha (i) signalling events—RGS1—celiac disease	0.000439	0.00888	CbGpPWpGaD
Droxidopa—ADRA2C—G alpha (i) signalling events—RGS1—celiac disease	0.000411	0.0083	CbGpPWpGaD
Droxidopa—DDC—Metabolism—LCT—celiac disease	0.000403	0.00814	CbGpPWpGaD
Droxidopa—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.00039	0.00789	CbGpPWpGaD
Droxidopa—ADRA2A—Platelet activation, signaling and aggregation—PLEK—celiac disease	0.000357	0.00722	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—ARHGAP31—celiac disease	0.000351	0.0071	CbGpPWpGaD
Droxidopa—ADRB3—GPCR ligand binding—CCR4—celiac disease	0.00035	0.00707	CbGpPWpGaD
Droxidopa—ADRA1D—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.000349	0.00706	CbGpPWpGaD
Droxidopa—ADRA2B—G alpha (i) signalling events—CCR4—celiac disease	0.00034	0.00687	CbGpPWpGaD
Droxidopa—ADRA2A—G alpha (i) signalling events—RGS1—celiac disease	0.000333	0.00674	CbGpPWpGaD
Droxidopa—ADRB1—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.000318	0.00643	CbGpPWpGaD
Droxidopa—ADRA2C—G alpha (i) signalling events—CCR4—celiac disease	0.000317	0.00641	CbGpPWpGaD
Droxidopa—ADRA2B—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.000315	0.00637	CbGpPWpGaD
Droxidopa—ADRB2—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.000311	0.00629	CbGpPWpGaD
Droxidopa—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.000299	0.00605	CbGpPWpGaD
Droxidopa—ADRB3—GPCR ligand binding—CCR3—celiac disease	0.000297	0.00601	CbGpPWpGaD
Droxidopa—ADRA1D—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.000297	0.006	CbGpPWpGaD
Droxidopa—ADRA2C—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.000294	0.00595	CbGpPWpGaD
Droxidopa—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.00029	0.00586	CbGpPWpGaD
Droxidopa—ADRA2B—G alpha (i) signalling events—CCR3—celiac disease	0.000289	0.00584	CbGpPWpGaD
Droxidopa—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.000273	0.00551	CbGpPWpGaD
Droxidopa—ADRB1—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.00027	0.00547	CbGpPWpGaD
Droxidopa—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.00027	0.00546	CbGpPWpGaD
Droxidopa—ADRA2C—G alpha (i) signalling events—CCR3—celiac disease	0.00027	0.00545	CbGpPWpGaD
Droxidopa—ADRA2B—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.000268	0.00542	CbGpPWpGaD
Droxidopa—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.000267	0.00539	CbGpPWpGaD
Droxidopa—ADRB2—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.000265	0.00535	CbGpPWpGaD
Droxidopa—ADRA2A—G alpha (i) signalling events—CCR4—celiac disease	0.000258	0.00521	CbGpPWpGaD
Droxidopa—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.000257	0.0052	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—RGS1—celiac disease	0.000256	0.00517	CbGpPWpGaD
Droxidopa—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.000254	0.00514	CbGpPWpGaD
Droxidopa—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.000252	0.0051	CbGpPWpGaD
Droxidopa—ADRA2C—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.00025	0.00506	CbGpPWpGaD
Droxidopa—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.000248	0.00502	CbGpPWpGaD
Droxidopa—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.000246	0.00498	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—PLEK—celiac disease	0.000243	0.0049	CbGpPWpGaD
Droxidopa—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.000239	0.00483	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—RGS1—celiac disease	0.000232	0.00469	CbGpPWpGaD
Droxidopa—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.000232	0.00468	CbGpPWpGaD
Droxidopa—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.00023	0.00464	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—ARHGAP31—celiac disease	0.000229	0.00463	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR ligand binding—CCR4—celiac disease	0.000228	0.0046	CbGpPWpGaD
Droxidopa—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.000227	0.00458	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—PLEK—celiac disease	0.000227	0.00458	CbGpPWpGaD
Droxidopa—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.000221	0.00446	CbGpPWpGaD
Droxidopa—ADRA2A—G alpha (i) signalling events—CCR3—celiac disease	0.000219	0.00443	CbGpPWpGaD
Droxidopa—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.000219	0.00442	CbGpPWpGaD
Droxidopa—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.000214	0.00434	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MYO9B—celiac disease	0.000213	0.0043	CbGpPWpGaD
Droxidopa—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.000211	0.00427	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—ARHGAP31—celiac disease	0.000209	0.00422	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—CCR4—celiac disease	0.000208	0.0042	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—ARHGAP31—celiac disease	0.000207	0.00418	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—CCR4—celiac disease	0.000206	0.00416	CbGpPWpGaD
Droxidopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.000205	0.00414	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—ARHGAP31—celiac disease	0.000204	0.00412	CbGpPWpGaD
Droxidopa—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.000203	0.00411	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—CCR4—celiac disease	0.000203	0.0041	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—CCR4—celiac disease	0.000198	0.00399	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR ligand binding—CCR3—celiac disease	0.000194	0.00392	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—ARHGAP31—celiac disease	0.000193	0.0039	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—CCR4—celiac disease	0.000192	0.00388	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—ARHGAP31—celiac disease	0.00019	0.00384	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—CCR4—celiac disease	0.000189	0.00382	CbGpPWpGaD
Droxidopa—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.000187	0.00379	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TAGAP—celiac disease	0.000185	0.00373	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—PLEK—celiac disease	0.000184	0.00372	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—CCR4—celiac disease	0.000179	0.00363	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—CCR3—celiac disease	0.000176	0.00357	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—LCT—celiac disease	0.000175	0.00354	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—CCR3—celiac disease	0.000175	0.00353	CbGpPWpGaD
Droxidopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.000174	0.00352	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—CCR3—celiac disease	0.000173	0.00349	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—ARHGAP31—celiac disease	0.000169	0.00341	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—CCR3—celiac disease	0.000168	0.0034	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—CCR4—celiac disease	0.000168	0.00339	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—RGS1—celiac disease	0.000167	0.00337	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—CCR3—celiac disease	0.000163	0.0033	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—CCR3—celiac disease	0.000161	0.00325	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—ARHGAP31—celiac disease	0.000157	0.00317	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—CCR4—celiac disease	0.000156	0.00315	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—CCR3—celiac disease	0.000153	0.00308	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—SH2B3—celiac disease	0.000152	0.00308	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—RGS1—celiac disease	0.000152	0.00307	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—RGS1—celiac disease	0.000151	0.00306	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—RGS1—celiac disease	0.00015	0.00304	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—RGS1—celiac disease	0.000148	0.003	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—CCR3—celiac disease	0.000143	0.00289	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—SH2B3—celiac disease	0.000142	0.00288	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—LCT—celiac disease	0.000142	0.00287	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—RGS1—celiac disease	0.00014	0.00284	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MYO9B—celiac disease	0.000139	0.0028	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—RGS1—celiac disease	0.000138	0.00279	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—RGS1—celiac disease	0.000138	0.00279	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—RGS1—celiac disease	0.000137	0.00277	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—RGS1—celiac disease	0.000137	0.00276	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—RGS1—celiac disease	0.000135	0.00273	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—CCR3—celiac disease	0.000133	0.00268	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—CCR4—celiac disease	0.000129	0.0026	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—RGS1—celiac disease	0.000128	0.00258	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MYO9B—celiac disease	0.000126	0.00255	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—RGS1—celiac disease	0.000126	0.00254	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MYO9B—celiac disease	0.000125	0.00253	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MYO9B—celiac disease	0.000124	0.0025	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—RGS1—celiac disease	0.000123	0.00248	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TAGAP—celiac disease	0.00012	0.00243	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—CCR4—celiac disease	0.000117	0.00237	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MYO9B—celiac disease	0.000117	0.00236	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—CCR4—celiac disease	0.000117	0.00236	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—CCR4—celiac disease	0.000116	0.00235	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—SH2B3—celiac disease	0.000116	0.00234	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MYO9B—celiac disease	0.000115	0.00233	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—CCR4—celiac disease	0.000115	0.00232	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—RGS1—celiac disease	0.000114	0.00231	CbGpPWpGaD
Droxidopa—PAH—Disease—CD80—celiac disease	0.000113	0.00229	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—RGS1—celiac disease	0.000112	0.00225	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TAGAP—celiac disease	0.00011	0.00221	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—CCR3—celiac disease	0.000109	0.00221	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—CCR4—celiac disease	0.000109	0.00219	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TAGAP—celiac disease	0.000109	0.00219	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TAGAP—celiac disease	0.000107	0.00217	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—CCR4—celiac disease	0.000107	0.00216	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—CCR4—celiac disease	0.000107	0.00215	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CCR4—celiac disease	0.000106	0.00214	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—CCR4—celiac disease	0.000106	0.00213	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CCR4—celiac disease	0.000104	0.00211	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—RGS1—celiac disease	0.000104	0.00209	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MYO9B—celiac disease	0.000102	0.00207	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TAGAP—celiac disease	0.000101	0.00205	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TAGAP—celiac disease	9.98e-05	0.00202	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—CCR3—celiac disease	9.97e-05	0.00202	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—CCR3—celiac disease	9.94e-05	0.00201	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—CCR3—celiac disease	9.88e-05	0.002	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CCR4—celiac disease	9.86e-05	0.00199	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—CCR3—celiac disease	9.75e-05	0.00197	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CCR4—celiac disease	9.7e-05	0.00196	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MYO9B—celiac disease	9.5e-05	0.00192	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—CCR4—celiac disease	9.49e-05	0.00192	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—CCR3—celiac disease	9.23e-05	0.00187	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—CCR3—celiac disease	9.08e-05	0.00184	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—CCR3—celiac disease	9.06e-05	0.00183	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CCR3—celiac disease	9.01e-05	0.00182	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—CCR3—celiac disease	8.97e-05	0.00181	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—RGS1—celiac disease	8.93e-05	0.00181	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TAGAP—celiac disease	8.86e-05	0.00179	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CCR3—celiac disease	8.86e-05	0.00179	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—CCR4—celiac disease	8.82e-05	0.00178	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—SH2B3—celiac disease	8.78e-05	0.00178	CbGpPWpGaD
Droxidopa—PAH—Disease—CD4—celiac disease	8.66e-05	0.00175	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CCR4—celiac disease	8.62e-05	0.00174	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CCR3—celiac disease	8.38e-05	0.00169	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CCR3—celiac disease	8.25e-05	0.00167	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TAGAP—celiac disease	8.23e-05	0.00166	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—RGS1—celiac disease	8.14e-05	0.00165	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—CCR3—celiac disease	8.07e-05	0.00163	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—RGS1—celiac disease	8.07e-05	0.00163	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CCR4—celiac disease	8.01e-05	0.00162	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—RGS1—celiac disease	7.96e-05	0.00161	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—RGS1—celiac disease	7.54e-05	0.00152	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—CCR3—celiac disease	7.5e-05	0.00152	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—RGS1—celiac disease	7.42e-05	0.0015	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CCR3—celiac disease	7.33e-05	0.00148	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CCR4—celiac disease	6.9e-05	0.0014	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CCR3—celiac disease	6.81e-05	0.00138	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—RGS1—celiac disease	6.59e-05	0.00133	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCR4—celiac disease	6.29e-05	0.00127	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCR4—celiac disease	6.23e-05	0.00126	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCR4—celiac disease	6.15e-05	0.00124	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RGS1—celiac disease	6.12e-05	0.00124	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CCR3—celiac disease	5.87e-05	0.00119	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCR4—celiac disease	5.82e-05	0.00118	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCR4—celiac disease	5.73e-05	0.00116	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—SH2B3—celiac disease	5.72e-05	0.00116	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCR3—celiac disease	5.35e-05	0.00108	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCR3—celiac disease	5.3e-05	0.00107	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCR3—celiac disease	5.23e-05	0.00106	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SH2B3—celiac disease	5.21e-05	0.00105	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SH2B3—celiac disease	5.17e-05	0.00104	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SH2B3—celiac disease	5.1e-05	0.00103	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCR4—celiac disease	5.09e-05	0.00103	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCR3—celiac disease	4.95e-05	0.001	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCR3—celiac disease	4.87e-05	0.000985	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SH2B3—celiac disease	4.83e-05	0.000975	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SH2B3—celiac disease	4.75e-05	0.00096	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCR4—celiac disease	4.73e-05	0.000956	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCR3—celiac disease	4.33e-05	0.000875	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SH2B3—celiac disease	4.22e-05	0.000853	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CD80—celiac disease	4.06e-05	0.000821	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCR3—celiac disease	4.02e-05	0.000813	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SH2B3—celiac disease	3.92e-05	0.000792	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CD80—celiac disease	2.65e-05	0.000535	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CD80—celiac disease	2.41e-05	0.000487	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CD80—celiac disease	2.39e-05	0.000483	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CD80—celiac disease	2.36e-05	0.000477	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CD80—celiac disease	2.23e-05	0.000451	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CD80—celiac disease	2.2e-05	0.000444	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CD80—celiac disease	1.95e-05	0.000394	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CD80—celiac disease	1.81e-05	0.000366	CbGpPWpGaD
